Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours

British Journal of Surgery

Volumn 90, Issue 3, 2003, Pages 332-339

  Langer, C ^a   Gunawan, B ^a   Schuler P ^a   Huber, W ^b   Fuzesi L ^a   Becker, H ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENETIC ASSOCIATION; HIGH RISK PATIENT; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; SURGICAL MORTALITY; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, CONNECTIVE TISSUE; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037342143     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4046     Document Type: Article

References (33)

1. Knuutila S, Björkqvist A-M, Autio K, Tarkkanen M, Wolf M, Monni O et al. DNA copy number amplifications in human neoplasms. Review of comparative genomic hybridization studies. Am J Pathol 1998; 152: 1107-1123.
2. El-Rifai W, Sarlomo-Rikala M, Andersson LC, Knuutila S, Miettinen M. DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. Cancer Res 2000; 60: 3899-3903.
3. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999; 30: 1213-1220.
4. Ng E-H, Pollock RE, Munsell MF, Atkinson EN, Romsdahl MM. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg 1992; 215: 68-77.
5. Sanders L, Silverman M, Rossi R, Braasch J, Munson L. Gastric smooth muscle tumors: diagnostic dilemmas and factors affecting outcome. World J Surg 1996; 20: 992-995.
6. Evans H. Smooth muscle tumors of the gastrointestinal tract. A study of 56 cases followed up for a minimum of 10 years. Cancer 1985; 56: 2242-2250.
7. Emory TS, Sobin LH, Lukes L, Lee DH, O'Leary TJ. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol 1999; 23: 82-87.
8. Peiper M, Schröder S, Zornig C. Stromal sarcoma of the stomach - a report of 20 surgically treated patients. Langenbecks Arch Surg 1998; 383: 442-446.
9. Tervahartiala P, Halavaara J. Radiology of GIST. Ann Chir Gynaecol 1998; 87: 291-292.
10. Levine MS. Textbook of Gastrointestinal Radiology. WB Saunders: Philadelphia, 1994; 628-683.
11. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF et al. Two hundred gastrointestinal stromal tumours: recurrence patterns and prognostic factors for survival. Ann Surg 2000; 231: 51-58.
12. Clary BM, DeMatteo RP, Lewis JJ, Leung D, Brennan MF. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison. Ann Surg Oncol 2001; 8: 290-299.
13. Ludwig DJ, Traverso LW. Gut stromal tumors and their clinical behavior. Am J Surg 1997; 173: 390-394.
14. Langer C, Bergmann F, Funke C, Füzesi L. Gastrointestinal stromal tumour (GIST) - problems of surgical treatment. Viszeralchirurgie 1999; 34: 208-211.
15. Yoshida M, Otani Y, Ohgami M, Kubota T, Kumai K, Mukai M et al. Surgical management of gastric leiomyosarcoma: evaluation of the propriety of laparoscopic wedge resection. World J Surg 1997; 21: 440-443.
16. Bandoh T, Isoyama T, Toyoshima H. Submucosal tumors of the stomach: a study of 100 operative cases. Surgery 1993; 113: 498-506.
17. Lehnert T. Gastrointestinal sarcoma (GIST) - a review of surgical management. Ann Chir Gynaecol 1998; 87: 297-305.
18. Ueyama T, Guo K-J, Hashimoto H, Daimaru Y, Enjoji M. A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors. Cancer 1992; 69: 947-955.
19. Hoos A, Lewis JJ, Brennan MF. Weichgewebssarkome - prognostische Faktoren und multimodale Therapie. Chirurg 2000; 71: 787-794.
20. Pierie JP, Choudry U, Muzikansky A, Yeap BY, Souba WW, Ott MJ et al. The effect of surgery, and grade on outcome of gastrointestinal stromal tumors. Arch Surg 2001; 136: 383-389.
21. Franquemont DW. Differentiation and risk assessment of gastrointestinal stromal tumors. Am J Clin Pathol 1995; 103: 41-47.
22. Sarlomo-Rikala M, El-Rifai W, Lahtinen T, Andersson LC, Miettinen M, Knuutila S et al. Different patterns of DNA copy number changes in gastrointestinal stromal tumors, leiomyomas, and schwannomas. Hum Pathol 1998; 29: 476-481.
23. Gunawan B, Bergmann F, Höer J, Langer C, Schumpelick V, Becker H et al. Biological and clinical significance of cytogenetic abnormalities in low-risk and high-risk gastrointestinal stromal tumors. Hum Pathol 2002; 33: 316-321.
24. Bergmann F, Gunawan B, Hermanns B, Höer J, Schumpelick V, Füzesi L et al. Cytogenetic and morphologic characteristics of gastrointestinal stromal tumors. Recurrent rearrangement of chromosome 1 and losses of chromosomes 14 and 22 as common anomalies. Verh Dtsch Ges Pathol 1998; 82: 275-278.
25. Breiner JA, Meis-Kindblom J, Kindblom L-G, McComb E, Liu J, Nelson M et al. Loss of 14q and 22q in gastrointestinal stromal tumors (pacemaker cell tumors). Cancer Genet Cytogenet 2000; 120: 111-116.
26. Sobin LH, Wittekind C. International Union Against Cancer: TNM Classification of Malignant Tumours (5th edn). J Wiley and Sons: New York, 1997.
27. Biesterfeld S, Kluppel D, Koch R, Schneider S, Steinhagen G, Mihalcea AM et al. Rapid and prognostically valid quantification of immunohistochemical reactions by immunohistometry of the most positive tumour focus. A prospective follow-up study on breast cancer using antibodies against MIB-1, PCNA, ER, and PR. J Pathol 1998; 185: 25-31.
28. Plaat BEC, Hollema H, Molenaar WM, Torn Broers GH, Pijpe J, Mastik MF et al. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol 2000; 18: 3211-3220.
29. Marci V, Casorzo L, Sarotto I, Dogliani N, Milazzo MG, Risio M et al. Gastrointestinal stromal tumor, uncommitted type, with monosomies 14 and 22 as the only chromosomal abnormalities. Cancer Genet Cytogenet 1998; 102: 135-138.
30. Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahatiala P, Tuveson D et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001; 344: 1052-1056.
31. Taniguchi M, Nishida T, Hirota S, Isozaki K, Ito T, Nomura T et al. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res 1999; 59: 4297-4300.
32. Fukuda R, Hamamoto N, Uchida Y, Furuta K, Katsube T, Kazumori H et al. Gastrointestinal stromal tumor with a novel mutation of KIT proto-oncogene. Intern Med 2001; 40: 301-303.
33. Van Oosterom AT, Judson I, Verweij J, Stroobants S, di Paola ED, Dimitrijevic S et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet 2001; 358: 1421-1423.